News

Lessons Behind This Product’s Success are Detailed in Millennium Research Group’s New Perception Pulse Study According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the recent favorable...

St. Jude Medical, Inc., a global medical device company, announced U.S. Food and Drug Administration (FDA) approval of its Assura™ portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy...

New family of implantable cardioverter defibrillators and cardiac resynchronization devices are enabled for remote monitoring Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced at...

Northwestern's Bluhm Cardiovascular Institute is the first in Illinois to perform this innovative procedure Patients with atrial fibrillation (A-fib) who cannot take blood thinners now have an alternative to reduce their risk of stroke,...

BIOTRONIK, a leading manufacturer of innovative medical technology, has developed the world’s first implantable cardiac defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and cardiac resynchronization therapy...

More Than 1,250 Niobe® ES (Epoch™ Solution) Cases Completed Stereotaxis, Inc. will highlight clinical results from the first 1,250 cases and the latest innovations for the Epoch™ platform, its new generation comprehensive solution for the...

Advanced Pacemaker Platform Designed to Treat Chronotropic Incompetence, which Affects up to 42 Percent of Pacemaker Patients Boston Scientific Corporation announced U.S. Food and Drug Administration (FDA) approval and market launch of its...

First Implantation of BIOTRONIK Lumax 740 ProMRI® ICD in Asia BIOTRONIK, a leading manufacturer of innovative medical technology, announced the first implantation of the new Lumax 740 ICD (implantable cardiac defibrillator) in Hong Kong....

Scientific Session and Academic Symposium to Highlight Use of Technology in Treatment of Atrial Fibrillation CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF),...

Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, announced several presentations related to the company’s TEMPASURE™ cardiac ablation catheter at the Heart Rhythm Society's 33rd...